A common apolipoprotein B signal peptide polymorphism modifies the relation between plasma non-esterified fatty acids and triglyceride concentration in men

Atherosclerosis

Volumn 152, Issue 1, 2000, Pages 9-17

  Halsall, D J ^a   Martensz, N D ^a   Luan, J ^b   Maison, P ^b   Wareham, N J ^b   Hales, C N ^a   Byrne, C D ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

ApoB; Blood lipids; Epidemiology glucose intolerance; Polymorphisms; Signal peptides

Indexed keywords

APOLIPOPROTEIN B; DNA; FATTY ACID; INSULIN; SIGNAL PEPTIDE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ALLELE; ARTICLE; DNA POLYMORPHISM; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTHROPOMETRY; APOLIPOPROTEINS B; BASE SEQUENCE; BODY MASS INDEX; COMPARATIVE STUDY; FATTY ACIDS, NONESTERIFIED; FEMALE; GENOTYPE; GLUCOSE TOLERANCE TEST; HUMAN; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); PROBABILITY; PROSPECTIVE STUDIES; PROTEIN SORTING SIGNALS; REGRESSION ANALYSIS; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SEX FACTORS; TRIGLYCERIDES;

EID: 0034283508     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00439-6     Document Type: Article

References (46)

1. Grundy S.M. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am. J. Cardiol. 26:1998;814A.
2. Hsueh W.A., Law R.E. Cardiovascular risk continuum: implications of insulin resistance and diabetes. Am. J. Med. 6:1998;1051A.
3. Ginsberg H.N. Role of lipid synthesis, chaperone proteins and proteasomes in the assembly and secretion of apoprotein B-containing lipoproteins from cultured liver cells. Clin. Exp. Pharmacol. Physiol. 24:1997;A292.
4. Hahn S.E., Goldberg D.M. Factors affecting the regulation of apo B secretion by liver cells. J. Clin. Lab. Anal. 9:1995;4319.
5. Millar J.S., Packard C.J. Heterogeneity of apolipoprotein B 100 containing lipoproteins. Curr. Opin. Lipidol. 9:1998;19702.
6. Pease R.J., Leiper J.M. Regulation of hepatic apolipoprotein-B-containing lipoprotein secretion. Curr. Opin. Lipidol. 7:1996;132.
7. White A.L., Graham D.L., LeGros J., Pease R.J., Scott J. Oleate-mediated stimulation of apolipoprotein B secretion from rat hepatoma cells: a function of the ability of apolipoprotein B to direct lipoprotein assembly and escape presecretory degradation. J. Biol. Chem. 267:1992;15657.
8. Sparks J.D., Phung T.L., Bolognino M., Sparks C.E. Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes. Biochem. J. 313:1996;567.
9. Bjornsson O.G., Duerden J.M., Bartlett S.M., Sparks J.D., Sparks C.E., Gibbons G.F. The role of pancreatic hormones in the regulation of lipid storage, oxidation and secretion in primary cultures of rat hepatocytes: short- and long term effects. Biochem. J. 281:1992;381.
10. Lewis G.F., Steiner G. Acute effects of insulin in the control of VLDL production in humans - implications for the insulin-resistant state. Diabetes Care. 19:1996;390.
11. Visvikis S., Chan L., Siest G., Drouin P., Boerwinkle E. An insertion deletion polymorphism in the signal peptide of the human apolipoprotein B gene. Hum. Genet. 84:1990;373.
12. Sturley S.L., Talmud P.J., Brasseur R., Culbertson M.R., Humphries S.E., Attie A.D. Human apolipoprotein B signal sequence variants confer a secretion-defective phenotype when expressed in yeast. J. Biol. Chem. 269:1994;21670.
13. Kammerer C.M., VandeBerg J.L., Haffner S.M., Hixson J.E. Apolipoprotein B apo B; signal peptide length polymorphisms are associated with apo B, low density lipoprotein cholesterol, and glucose levels in Mexican Americans. Atherosclerosis. 120:1996;375.
14. Turner P.R., Talmud P.J., Visvikis S., Ehnholm C., Tiret L. DNA polymorphisms of the apoprotein B gene are associated with altered plasma lipoprotein concentrations but not with perceived risk of cardiovascular disease: European Atherosclerosis Research Study. Atherosclerosis. 116:1995;2214.
15. Friedlander Y., Berry E.M., Eisenberg S., Stein Y., Leitersdorf E. Plasma lipids and lipoproteins response to a dietary challenge: analysis of four candidate genes. Clin. Genet. 47:1995;12.
16. Bohn M., Bakken A., Erikssen J., Berg K. The apolipoprotein B signal peptide insertion/deletion polymorphism is not associated with myocardial infarction in Norway. Clin. Genet. 45:1994;255.
17. Hansen P.S., Klausen I.C., Lemming L., Gerdes L.U., Gregersen N., Faergeman O. Apolipoprotein B gene polymorphisms in ischemic heart disease and hypercholesterolemia: effects of age and sex. Clin. Genet. 45:1994;78.
18. Saha N., Tay J.S., Heng C.K., Humphries S.E. DNA polymorphisms of the apolipoprotein B gene are associated with obesity and serum lipids in healthy Indians in Singapore. Clin. Genet. 44:1993;1130.
19. Visvikis S., Cambou J.P., Arveiler D. et al. Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls. 'The ECTIM study'. Hum. Genet. 90:1993;561.
20. Hixson J.E., McMahan C.A., McGill H.C. Jr, Strong J.P. Apo B insertion/deletion polymorphisms are associated with atherosclerosis in young black but not young white males. Pathobiological determinants of atherosclerosis in youth PDAY; Research Group. Arterioscler. Thromb. 12:1992;1023.
21. Saha N., Tay J.S., Chew L.S. Influence of apolipoprotein B signal peptide insertion/deletion polymorphism on serum lipids and apolipoproteins in a Chinese population. Clin. Genet. 41:1992;152.
22. Renges H.H., Wile D.B., McKeigue P.M., Marmot M.G., Humphries S.E. Apolipoprotein B gene polymorphisms are associated with lipid levels in men of South Asian descent. Atherosclerosis. 91:1991;267.
23. Glisic S., Prljic J., Radovanovic N., Alavantic D. Study of apoB gene signal peptide insertion/deletion polymorphism in a healthy Serbian population: no association with serum lipid levels. Clin. Chim. Acta. 263:1997;57.
24. Gaffney D., Freeman D.J., Shepherd J., Packard C.J. The ins/del polymorphism in the signal sequence of apolipoprotein B has no effect on lipid parameters. Clin. Chim. Acta. 218:1993;131.
25. Boerwinkle E., Chen S.H., Visvikis S., Hanis C.L., Siest G., Chan L. Signal peptide-length variation in human apolipoprotein B gene. Molecular characteristics and association with plasma glucose levels. Diabetes. 40:1991;15394.
26. Wu J.H., Wen M.S., Lo S.K., Chern M.S. Increased frequency of apolipoprotein B signal peptide sp24/24 in patients with coronary artery disease. General allele survey in the population of Taiwan and comparison with Caucasians. Clin. Genet. 45:1994;255.
27. Hong S.H., Lee C.C., Kim J.Q. Genetic variation of the apolipoprotein B gene in Korean patients with coronary artery disease. Mol. Cells. 7:1997;521.
28. Corbo R.M., Vilardo T., Mantuano E., Ruggeri M., Gemma A.T., Scacchi R. Apolipoproteins B and E, and angiotensin I-converting enzyme ACE; genetic polymorphisms in Italian women with coronary artery disease CAD; and their relationships with plasma lipid and apolipoprotein levels. Clin. Genet. 52:1997;77.
29. Zilversmit D.B. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride rich remnant lipoproteins. Clin. Chem. 41(1):1995;153.
30. Byrne C.D., Wareham N.J., Mistry P.K. et al. The association between free fatty acid concentrations and triglyceride-rich lipoproteins in the post-prandial state is altered by a common deletion polymorphism of the apo B signal peptide. Atherosclerosis. 127:1996;352.
31. Williams D.R., Wareham N.J., Brown D.C. et al. Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet. Med. 121:1995;30.
32. Sobey W.J., Beer S.F., Carrington C.A. et al. Sensitive and specific two site immunoradiometric assays for human insulin, proinsulin, 65-6 split and 323 split proinsulins. Biochem. J. 260:1989;53541.
33. Alpha B., Cox L., Crowther N., Clark P.M.S., Hales C.N. Sensitive amplified immunoenzymometric assays IEMA; for human insulin and intact proinsulin. Eur. J. Clin. Chem. Clin. Biochem. 30:1992;272.
34. Laakso M. How good a marker is insulin level for insulin resistance? Am. J. Epidemiol. 137:1993;959.
35. Phillips D.I., Clark P.M., Hales C.N., Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet. Med. 11:1994;286.
36. WHO study group. Diabetes mellitus. Technical report series 1994;No 727. WHO, Geneva.
37. Shimizu S. Enzymatic determination of serum free fatty acids: a colorimetric method. Anal. Biochem. 107:1980;19398.
38. Byrne C.D., Wareham N.J., Day N.E., McLeish R., Williams D.R., Hales C.N. Decreased non-esterified fatty acid suppression and features of the insulin resistance syndrome occur in a sub-group of individuals with normal glucose tolerance. Diabetologia. 38:1995;1358.
39. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
40. Boerwinkle E., Lee S.S., Butler R., Schumaker V.N., Chan L. Rapid typing of apolipoprotein B DNA polymorphisms by DNA amplification. Association between Ag epitopes of human apolipoprotein B00, a signal peptide insertion/deletion polymorphism, and a 3′-flanking DNA variable number of tandem repeats polymorphism of the apolipoprotein B gene. Atherosclerosis. 81:1990;2252.
41. Mullis K., Faloona F., Scharf S., Saiki R., Horn G., Erlich H. Specific enzymatic amplification of DNA in vitro:the polymerase chain reaction. Cold Spring Harb. Symp. Quant. Biol. 51(1):1986;263.
42. Day I.N., Humphries S.E., Richards S., Norton D., Reid M. High-throughput genotyping using horizontal polyacrylamide gels with wells arranged for microplate array diagonal gel electrophoresis MADGE. Biotechniques. 19:1995;830.
43. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int. J. Obes. Relat. Metab. Disord. 20:1996;29102.
44. Peacock R.E., Karpe F., Talmud P.J., Hamsten A., Humphries S.E. Common variation in the gene for apolipoprotein B modulates postprandial lipoprotein metabolism: an hypothesis generating study. Atherosclerosis. 116:1995;1355.
45. Syvanne M., Talmud P.J., Humphries S.E. et al. Determinants of postprandial lipemia in men with coronary artery disease and low levels of HDL cholesterol. J. Lipid Res. 38:1997;1463.
46. Talmud P., Lins L., Brasseur R. Prediction of signal peptide functional properties: a study of the orientation and angle of insertion of yeast invertase mutants and human apolipoprotein B signal peptide variants. Protein Eng. 9:1996;3171.